Latest Breaking News On - Total vitiligo area scoring index - Page 2 : comparemela.com

This new data from the phase 2b trial on povorcitinib could lead to developments in the dermatology space for vitiligo patients.

France generalKhaled ezzedineKurt brownPovorcitinib global program head at incyteEuropean academy of dermatologyEuropean academyTotal vitiligo area scoring indexVitiligo area scoring indexVice presidentPovorcitinib global program headAnnounces positiveWeek dataStudy evaluating povorcitinibExtensive nonsegmentalPovorcitinib significantly improves totalFacial vitiligo